Bernard Coulie

Bernard Coulie, M.D., Ph.D., is currently serving as President and Chief Executive Officer of Pliant Therapeutics. Under his leadership, Pliant raised $124 Million in venture and private equity capital so far. He joined Pliant from ActoGeniX, where he was CEO, Chief Medical Officer and Co-Founder. In these positions, Dr. Coulie played an integral role in advancing the company’s unique technology platform for oral delivery of biologics from early discovery stage through Phase 2 studies. Prior to ActoGeniX, Dr. Coulie held various positions at Johnson & Johnson Pharmaceutical Research and Development Europe where he managed a portfolio of products in GI, metabolic diseases and inflammation/immunology. Dr. Coulie was trained as a gastroenterologist at University of Leuven (Belgium) and at Mayo Clinic (Rochester, MN).